Mostrando 1 - 2 resultados de 2 para a busca 'Y. Linhares', tempo de busca: 0.02s Refinar Resultados
  1. 1
    PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS-5)

    PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS-5) por M. Hamadani, Y. Linhares, M. D. Gandhi, M. Chung, H. Adamis, D. Ungar, C. Carlo-Stella, E. Kingsley, J. Depaus, S. Snauwaert, M. Kwiatek, J. López-Jiménez

    Publicado em 2022-06-01
    Obter o texto integral
    Artigo
  2. 2
    P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 STUDY (SGN35 027 PART B)

    P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 ST... por H. Lee, I. W. Flinn, J. Melear, R. Ramchandren, J. Friedman, J. M. Burke, Y. Linhares, M. Raval, R. Chintapatla, T. A. Feldman, H. Yimer, M. Islas-Ohlmayer, A. Dean, V. Rana, M. D. Gandhi, J. Renshaw, A. L. Gillespie-Twardy, L. Ho, M. Puhlmann, W. Guo, C. A. Yasenchak

    Publicado em 2022-06-01
    Obter o texto integral
    Artigo

Ferramentas de busca: